Since almost 20 y it is known that seizures may trigger Takotsubo syndrome (TTS). Since then it has been repeatedly proposed that TTS could be the cause of sudden unexpected death in epilepsy (SUDEP).
A review of the so far reported cases of seizure-triggered TTS was carried out to see how often seizuretriggered TTS is fatal.
Altogether 59 papers were identified which reported altogether 74 patients with seizure-triggered TTS. Age was reported in 70 patients and ranged from 18 to 82 y. Gender was reported in 70 cases and was female in 60 cases (86%). The type of triggering seizure was reported in 47 cases. In 28 patients (60%) the trigger was a generalized tonic clonic seizure, in 15 cases (32%) a generalized status epilepticus, and in 3 cases a complex partial seizure. The outcome was mentioned in 63 of the 74 patients. Full recovery was reported in 61 cases (97%), incomplete recovery in none of the patients, and a fatal outcome in 2 patients (3%).
Fatalities are rare in patients experiencing seizure-triggered TTS. This is why seizure-triggered TTS does not seem to play a major role in the pathogenesis of SUDEP.
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Results
Altogether 59 papers matching the search terms were selected. Full access was available to 47 articles (80%) and 12 papers were accessible only as an abstract. Fifty-one papers were case reports or single cases with epilepsy in a cohort study. Eight papers reported more than 1 patient but none of the papers reported more than 5 patients (Table 1) . Altogether, 74 patients with epilepsytriggered TTS were identified (Table 1) . Among the nine papers reporting >2 patients, all were accessible as full papers. In the study with 5 patients nothing is reported about the cause, type, or treatment of seizures [5] . None of the five patients experienced cardiac symptoms prior or during hospitalization [5] . The only indication for cardiac disease in these 5 patients was elevated troponin, why further cardiologic investigations were carried out, revealing TTS. The first paper about seizure-triggered TTS was provided by Sharkey et al. in 1998 . In a series of 22 patients with TTS, three had generalized seizures prior to the development of TTS [6] . Two of them were female, age ranged between 40 and 73 y, and all had a favorable outcome. Unfortunately, no information about the cause and treatment of epilepsy and the TTS type were provided [6] . Among all 74 patients with seizure-triggered TTS so far reported, age was reported in 70 patients, ranging from 18 to 82 y. Gender was reported in 70 cases and was female in 60 (86%) and male in 10 (14%) cases. The type of triggering seizure was reported in 47 cases. In 28 patients (60%) the trigger was a generalized tonic clonic seizure (TCS), in 15 cases (32%) a generalized status epilepticus, and in 3 cases a complex partial seizure (Table 1 ). Data about the antiepileptic medication prior to TTS were provided for 18 patients. In some studies it was unclear if the given AED was taken already prior to TTS or prescribed after the triggering seizure. The type of TTS was reported in 59 patients, of which 48 (81%) presented with the classical type, 7 with the midventricular type, 1 with the inverted (inverse) type, and 3 with the global type ( Table 1) . Treatment for TTS was given in 15 cases (Table 1) . No treatment for TTS was provided in 19 cases. Only 1 of those who received no treatment died. The outcome was reported in 63 of the 74 patients so far published. Full recovery of TTS was reported in 61 cases (97%), incomplete recovery in none of the patients, and a fatal outcome in 2 patients (3%).
Discussion
This mini-review shows that TTS is increasingly recognized as a possible complication of generalized seizures. Diagnosing TTS in patients after a seizure is essential since treatment of TTS may improve the outcome of affected patients. However, of the 19 patients who did not receive treatment only one died and of the 14 patients who received treatment, none died. Though it is speculated that TTS is one possible mechanism to explain sudden unexpected death in epilepsy (SUDEP), the present review argues against a strong causal relation. Only 3% of the patients with seizure-triggered TTS died during or after the event. In 97% of the cases the outcome of seizure-triggered TTS was favorable, irrespective if TTS was treated or not, suggesting that TTS without complications is not responsible for SUDEP in a significant number of cases. Only if TTS is complicated by non-sustained ventricular arrhythmias or asystole it is conceivable that TTS secondarily causes SUDEP. More frequently than uncomplicated TTS, ventricular arrhythmias or a pulmonary complication may cause SUDEP. A further argument against a strong role of TTS in the pathomechanism of SUDEP is that TTS generally carries a favorable outcome, disregarding the underlying trigger. Only in patients with subarachnoid bleeding the outcome of TTS is fatal in 34%, and thus higher compared to patients with seizure-triggered TTS, possibly due to the increased mortality of the underlying neurologic disease.
In conclusion this minireview shows that seizure-triggered TTS has been reported in 74 cases since its first description in 1998 [6] . No information about the prevalence of TTS among epilepsy patients has been provided so far. Age at occurrence of TTS ranges from 18 to 82 y [7, 8] . There is a striking female preponderance. All types of TTS may be triggered by seizures but the classical type prevails. The outcome is favorable in 97% of the cases, irrespective of treating or not treating TTS, making it rather unlikely that TTS plays a strong role in the pathomechanism of SUDEP. It appears that patients with generalized seizures do not need to receive beta-blockers for prophylactic reasons to prevent TTS.
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